Evidence map›Paper›PMID 32973342›Full record

ArticleEuropean journal of human genetics : EJHG2021

NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.

Nina McTiernan, Harinder Gill, Carlos E Prada, Harry Pachajoa, Juliana Lores, CAUSES study, Thomas Arnesen

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Nina McTiernanDepartment of Biomedicine, University of Bergen, N-5020, Bergen, Norway.ORCID http://orcid.org/0000-0002-1749-6933
Harinder GillDepartment of Medical Genetics, Children's and Women's Health Centre of British Columbia, Vancouver, BC, V6H 3N1, Canada.
Carlos E PradaDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, 45229, Cincinnati, OH, USA.
Harry PachajoaCentro de Investigaciones en Anomalías Congénitas y Enfermedades Raras Universidad Icesi, Cali, Colombia.ORCID http://orcid.org/0000-0003-2672-0439
Juliana LoresCentro de Investigaciones en Anomalías Congénitas y Enfermedades Raras Universidad Icesi, Cali, Colombia.ORCID http://orcid.org/0000-0002-0679-4249
CAUSES study
Thomas ArnesenDepartment of Biomedicine, University of Bergen, N-5020, Bergen, Norway. Thomas.Arnesen@uib.no.
Fundación Valle del Lili · COUniversity of Bergen · NOChildren's & Women's Health Centre of British Columbia · CACincinnati Children's Hospital Medical Center · USHaukeland University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nearly half of all human proteins are acetylated at their N-termini by the NatA N-terminal acetyltransferase complex. NAA10 is evolutionarily conserved as the catalytic subunit of NatA in complex with NAA15, but may also have NatA-independent functions. Several NAA10 variants are associated with genetic disorders. The phenotypic spectrum includes developmental delay, intellectual disability, and cardiac abnormalities. Here, we have identified the previously undescribed NAA10 c.303C>A and c.303C>G p.(N101K) variants in two unrelated girls. These girls have developmental delay, but they both also display hemihypertrophy a feature normally not observed or registered among these cases. Functional studies revealed that NAA10 p.(N101K) is completely impaired in its ability to bind NAA15 and to form an enzymatically active NatA complex. In contrast, the integrity of NAA10 p.(N101K) as a monomeric acetyltransferase is intact. Thus, this NAA10 variant may represent the best example of the impact of NatA mediated N-terminal acetylation, isolated from other potential NAA10-mediated cellular functions and may provide important insights into the phenotypes observed in individuals expressing pathogenic NAA10 variants.

Indexed as

AcetylationAmino Acid SequenceAnimalsChild, PreschoolFemaleGenetic Predisposition to DiseaseHeLa CellsHumansIntellectual DisabilityMiceModels, MolecularMutationN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EPhenotypeProtein ConformationNAA10 protein, humanN-Terminal Acetyltransferase AN-Terminal Acetyltransferase E

Identifiers

PMID32973342
PMCPMC7868364
OpenAlexW3089060938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.